Insider Shareholders with Direct Ownership of Genocea Biosciences, Inc. (GNCA)
This section provides a comprehensive overview of the insiders with direct ownership of Genocea Biosciences, Inc. (GNCA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
GENOCEA BIOSCIENCES, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
William D Clark
President and CEO |
341,258 | 136,626 | 304,377 $0 | 8 |
Jun 02, 2022
Reduced 1.3%
|
|
Jessica Baker Flechtner
Chief Scientific Officer |
87,500 | 22,664 | 89,027 $0 | 6 |
Jun 02, 2022
Reduced 1.74%
|
|
Diantha Duvall
CHIEF FINANCIAL OFFICER |
75,000 | 29,598 | 75,388 $0 | 6 |
Jun 02, 2022
Reduced 1.77%
|
|
Girish N Aakalu
CHIEF BUSINESS OFFICER |
62,500 | 3,360 | 74,459 $0 | 4 |
Apr 04, 2022
Reduced 1.28%
|
|
Thomas Andrew Davis
CHIEF MEDICAL OFFICER |
62,500 | 3,808 | 68,330 $0 | 4 |
Apr 04, 2022
Reduced 1.57%
|
|
Raymond D Stapleton Jr
CHIEF TECHNOLOGY OFFICER |
43,750 | 2,500 | 43,750 $0 | 2 |
May 25, 2022
Reduced 5.41%
|
|
Jacquelyn L Sumer
CHIEF LEGAL & COMPLIANCE OFF |
37,500 | 2,500 | 43,000 $0 | 2 |
Jun 01, 2022
Reduced 5.49%
|
|
George Siber
Director |
0 | 20,425 | 252 $0 | 1 |
May 27, 2022
Reduced 98.78%
|
|
New Enterprise Associates 16, L.P.
> 10% Shareholder |
0 | 10,376,936 | 0 $0 | 2 |
May 25, 2022
Reduced 100.0%
|